← All organizations
Highest phase reached
Phase 3
First clinical trial
May 31, 2011Last known activity
Sep 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 5 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06465901CollaboratorN/ASep 1, 2024
- NCT05169554CollaboratorPhase 2Dec 1, 2021
- NCT04386070CollaboratorPhase 3May 15, 2020
- NCT01634932CollaboratorN/AJul 31, 2012
- NCT01321099CollaboratorN/AMay 31, 2011
Details
- Last known activity
- Sep 1, 2024